Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Do individuals with and without depression value depression differently? And if so, why?

Papageorgiou K, Vermeulen KM, Schroevers MJ, Stiggelbout AM, Buskens E, Krabbe PF, van den Heuvel E, Ranchor AV.

Qual Life Res. 2015 Nov;24(11):2565-75. doi: 10.1007/s11136-015-1018-3. Epub 2015 Jun 3.

2.

Comparison of general population, patient, and carer utility values for dementia health states.

Rowen D, Mulhern B, Banerjee S, Tait R, Watchurst C, Smith SC, Young TA, Knapp M, Brazier JE.

Med Decis Making. 2015 Jan;35(1):68-80. doi: 10.1177/0272989X14557178. Epub 2014 Nov 10.

3.

Time trade-off: one methodology, different methods.

Attema AE, Edelaar-Peeters Y, Versteegh MM, Stolk EA.

Eur J Health Econ. 2013 Jul;14 Suppl 1:S53-64. doi: 10.1007/s10198-013-0508-x.

4.

Cost-effectiveness of family psychoeducation to prevent relapse in major depression: results from a randomized controlled trial.

Shimodera S, Furukawa TA, Mino Y, Shimazu K, Nishida A, Inoue S.

BMC Psychiatry. 2012 May 14;12:40. doi: 10.1186/1471-244X-12-40.

5.

Physical victimization of rural methamphetamine and cocaine users.

Kramer TL, Borders TF, Tripathi S, Lynch C, Leukefeld C, Falck RS, Carlson RG, Booth BM.

Violence Vict. 2012;27(1):109-24.

6.

Empirical validation of patient versus population preferences in calculating QALYs.

Weyler EJ, Gandjour A.

Health Serv Res. 2011 Oct;46(5):1562-74. doi: 10.1111/j.1475-6773.2011.01268.x. Epub 2011 Apr 21.

7.

Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.

Lynch FL, Dickerson JF, Clarke G, Vitiello B, Porta G, Wagner KD, Emslie G, Asarnow JR Jr, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes T, DeBar L, McCracken JT, Strober M, Suddath RL, Spirito A, Onorato M, Zelazny J, Iyengar S, Brent D.

Arch Gen Psychiatry. 2011 Mar;68(3):253-62. doi: 10.1001/archgenpsychiatry.2011.9.

8.

Predictors of health-related quality-of-life utilities among persons with posttraumatic stress disorder.

Doctor JN, Zoellner LA, Feeny NC.

Psychiatr Serv. 2011 Mar;62(3):272-7. doi: 10.1176/ps.62.3.pss6203_0272.

9.

Stimulant use by young adult African Americans in a rural community: a pipeline to prison?

Kramer TL, Bell-Tolliver L, Tripathi SP, Booth BM.

Subst Use Misuse. 2011;46(6):716-27. doi: 10.3109/10826084.2010.526981. Epub 2010 Nov 3.

10.

Valuation of scleroderma and psoriatic arthritis health states by the general public.

Khanna D, Frech T, Khanna PP, Kaplan RM, Eckman MH, Hays RD, Ginsburg SS, Leonard AC, Tsevat J.

Health Qual Life Outcomes. 2010 Oct 1;8:112. doi: 10.1186/1477-7525-8-112.

11.

Discrepancy in rating health-related quality of life of depression between patient and general population.

Gerhards SA, Evers SM, Sabel PW, Huibers MJ.

Qual Life Res. 2011 Mar;20(2):273-9. doi: 10.1007/s11136-010-9746-x. Epub 2010 Sep 30.

Supplemental Content

Support Center